Advertisement

Infectious Diseases Editors' Choice: Top Stories of 2013

Letter to Readers |
December 31, 2013

Infectious Diseases Editors' Choice: Top Stories of 2013

  1. Larry M. Baddour, MD

A perspective on the most important research in the field from the past year

  1. Larry M. Baddour, MD

Dear Readers,

This has been an exciting year for us, with organizational changes that are reflected in our new title: NEJM Journal Watch Infectious Diseases. We remain devoted to providing clinicians with the information they need to give their patients the best care — and, as part of NEJM Group, we are now poised to do that better than ever.

The top infectious diseases stories this year vary considerably, but some common themes are evident. First, novel therapies are important — fecal transplant for recurrent Clostridium difficile infection, dual β-lactam therapy for enterococcal endocarditis, and tenofovir treatment of hepatitis B virus infection with reversal of cirrhosis, for example. Second, the problem of antibiotic resistance is growing, complicating the treatment of many bacterial infections, including gonorrhea. Third, infection-control practices relating to compounding of medicinal agents need to be reevaluated, as was shown by a major outbreak of fungal infections in patients who received contaminated steroid injections. Fourth, the world of infectious diseases continues to expand with newly recognized pathogens, including the Middle East respiratory syndrome coronavirus.

Fungal Meningitis After a Contaminated Epidural Steroid Injection

HBV Treatment Reverses Cirrhosis

Donor Feces for Recurrent Clostridium difficile Infection

Agricultural Antibiotic Use and Antibiotic Resistance

Ampicillin plus Ceftriaxone for Enterococcus faecalis Endocarditis

MERS Coronavirus — An Update

Gonococcal Treatment Failure Due to Cephalosporin Resistance Now in North America

Novel Avian-Origin Influenza A (H7N9) Virus in China

The Human Gut Virome

Can Gloves and Gowns Prevent the Spread of Antibiotic-Resistant Bacteria?

  • Disclosures for Larry M. Baddour, MD at time of publication Editorial boards UpToDate Leadership positions in professional societies American Heart Association (Chairman, Rheumatic Fever, Endocarditis, Kawasaki Disease Committee)

Reader Comments (7)

le tuyet hoa Physician, Endocrinology, hospital university

I always follow up all the articles in NEJM, especialize in endocrinology and infectious diseases

Muhammad Ashraf Physician, Pulmonary Medicine, SIMS / Services Hospital, Lahore

NEJM had great in CME of physicians. Thanks

OLUMUYIWA OWOLABI Physician, Infectious Disease, Medical Research Unit, The Gambia

This forum has been helpful to my practice and gives me updates in real time about recent advances in medical sciences. This latest in this category was the publication on vitamin D binding proteins in blacks and whites amongst others.

WALERIA HRYNIEWICZ Physician, Infectious Disease
Competing Interests: Lectures for Pfizer, AstraZeneca Meetings support from Astellas, Pfizer

Selected topics are well balanced. I will appreciate a review on new rapid diagnostics methods and critical review on new antimicrobial agents

WALERIA HRYNIEWICZ Physician, Infectious Disease, National Medicines Institute
Competing Interests: Lectures for Pfizer, AstraZeneca, BioMerieux Support for meetings from Astellas, Pfizer,

The topics selected are well balanced. I would be happy to get a review on new rapid methods in infectious diseases and also critical review on new antibacterial agents

ELENA BARBU Physician, Infectious Disease, the dispensary for pneumology, paediatric department, Brasov town, Sitei street, no.17,Romania

Dear colleagues,
Thank You for the opportunity to read Your messages! I am working in respiratory diseases in children and my doctoral studies have been about the treatment in tuberculosis in children. I am interested in these themes and I find a lot of interesting medical news in Your online messages.
I wish all the best for 2014,
With consideration,dr. Elena Barbu,MD,PhD.

JOHN BREEN

great

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement